Jacob Vincent Micallef - 16 Dec 2022 Form 4 Insider Report for VOLITIONRX LTD (VNRX)

Role
Chief Scientific Officer
Signature
/s/ Jacob Vincent Micallef
Issuer symbol
VNRX
Transactions as of
16 Dec 2022
Net transactions value
+$71,884
Form type
4
Filing time
20 Dec 2022, 09:04:17 UTC
Previous filing
14 Oct 2022
Next filing
13 Jan 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction VNRX Common Stock Purchase $14,384 +7,339 +4.7% $1.96 163,392 16 Dec 2022 Direct
transaction VNRX Common Stock Purchase $57,500 +25,000 +15% $2.30 188,392 19 Dec 2022 Direct
holding VNRX Common Stock 35,000 16 Dec 2022 By Spouse
holding VNRX Common Stock 38,113 16 Dec 2022 By Borlaug Limited F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares of common stock are held directly by Borlaug Limited. The reporting person is a controlling director of Borlaug Limited and has voting and dispositive control over the shares of common stock held by Borlaug Limited